Performance
-
1W
-
1M
-
3M
-
6M
+96.63%
YTD
+180.84%
1Y
Profile
Ambrx Biopharma Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system. It focuses on portfolio of clinical and preclinical programs designed to optimize efficacy and safety in multiple cancer indications, including ARX517, its proprietary antibody-drug conjugate (ADC) targeting the prostate-specific membrane antigen (PSMA) and ARX788, its proprietary ADC targeting HER2. The company also has preclinical and clinical collaborations with multiple partners on drug candidates using Ambrx technology. The company was incorporated in 2003 and is headquartered in La Jolla, California.
Recent News & Updates
- 2024-03-06 13:20
Ambrx Shareholders Approve Acquisition by Johnson & Johnson(GlobeNewswire)
- 2024-03-06 00:20
Ambrx Shareholders Approve Acquisition by Johnson & Johnson(Globenewswire)
- 2024-02-19 20:40
- 2024-02-12 00:43
- 2024-02-07 23:26
- 2024-01-29 10:02
- 2024-01-25 02:23
- 2024-01-24 19:03
- 2024-01-23 01:45
- 2024-01-16 21:42
- 2024-01-10 02:07
- 2024-01-08 21:25
- 2024-01-08 07:35
Ambrx Announces Sale to Johnson & Johnson(GlobeNewswire)
- 2024-01-08 01:51
- 2024-01-07 23:22
Why Is Ambrx Biopharma (AMAM) Stock Up 100% Today?(Investorplace)
- 2024-01-07 22:35
- 2024-01-07 19:08
- 2024-01-07 18:35
Ambrx Announces Sale to Johnson & Johnson(Globenewswire)
- 2024-01-07 18:30
- 2023-12-14 08:48
Ambrx to be Added to the NASDAQ Biotechnology Index (NBI)(GlobeNewswire)
- 2023-12-13 19:48
Ambrx to be Added to the NASDAQ Biotechnology Index (NBI)(globenewswire)
- 2023-11-28 08:19
- 2023-11-27 19:19
- 2023-10-25 22:32
5 Best Performing NASDAQ Stocks in 2023(insidermonkey)
- 2023-10-23 08:00
- 2023-10-22 20:00
- 2023-10-16 07:56
- 2023-10-15 19:56
- 2023-09-30 23:00
Top Stocks for October 2023(investopedia)
- 2023-09-25 20:30
Page 1 of 4
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.